Position in KALA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$26,330
-$21,210 QoQ
Shares Held
3,044
+78.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KALA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,794,912 across 147 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | 29,790 | $3,954,026 | |||
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in KALA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,330 | 152,197 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $47,540 | 85,505 | Shares | Defined | 2026-02-23 | |
| 2024-06-30 | $220,506 | 31,101 | Shares | Defined | 2024-08-09 | |
| 2022-09-30 | $14,336 | 64,873 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $22,390 | 74,636 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $193,905 | 140,511 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $152,739 | 126,231 | Shares | Defined | 2022-02-17 | |
| 2020-06-30 | $134,696 | 12,816 | Shares | Defined | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||